Submit abstract    

Deadline for submission of abstracts: Jun 12, 2026.

Online submission will open here shortly.

To submit your abstract, please follow the instructions here.

Abstracts are invited by Jun 12, 2026. A selection of the best abstracts will be nominated for both oral and poster presentations. All other abstracts will be presented as poster presentations only.

The Summit will consider abstracts focused on the following topics:

• Changing epidemiology of diabetes
• Modifiable risk factors
• Primary prevention of type 2 diabetes
• Secondary prevention of type 2 diabetes
• Tertiary prevention of type 2 diabetes
• The role of primary care in diabetes prevention
• Health policy response to diabetes prevention
• Global response to diabetes prevention
• Prevention of gestational diabetes
• Prevention of progression of type 1 diabetes
• Determinants of diabetes (socio-economic, commercial, environmental)

All abstracts should be original research. We will consider clinical trials, prospective studies, retrospective analyses, meta-analyses, and observational cohort or case-control studies. However, reviews, opinion pieces, case series, or case reports will not be considered. The research should have ethics approval and clinical trials should be prospectively registered in a publicly accessible database. We also encourage registration of meta-analyses.

We look forward to reading your work and welcoming you to the Summit.

Notes for authors

All abstracts will be refereed and a criterion of rejection will be lack of originality.

A condition of submission is that, if accepted, the paper will be presented at the conference by one of the authors.

Successfully submitted abstracts will be acknowledged with an electronic receipt including an abstract reference number, which should be quoted in all correspondence.